1) deoxypyridinoline
脱氧吡啶啉
1.
【Objective】 To investigate the variation of serum carboxyterminal propeptide of typeⅠprocollagen(PICP),urine deoxypyridinoline(DPD) and their relationships with sex,age,body weight,body length,and body mass index in infants and toddlers.
【目的】探讨骨Ⅰ型胶原形成标志物Ⅰ型前胶原羧基端前肽(carboxyterminal propeptide of type I procol-lagen,PICP)和分解标志物脱氧吡啶啉(deoxypyridinoline,DPD)与婴幼儿生长发育的关系。
2.
Objective To investigate the level of CTX-II and deoxypyridinoline (DPD) in serum of experimental rats induced by T-2 toxin, to explore its roles as the biomarker of articular cartilage damage.
目的观察实验性大鼠关节软骨损伤时血清中II型胶原降解产物Ⅱ型胶原羧基端端肽(CTX-II)和脱氧吡啶啉(DPD)水平,探讨其在软骨损伤中的分子生物标志物作用。
2) Dpd
脱氧吡啶啉
1.
Objective To investigate the role of bone metabolic indices in the diagnosis and monitoring of therapeutic effects in osteoporosis, the serum tartrate-resistant acid phosphatase form 5b(TRACP5b) level and other parameters such as Dpd in urine of osteoporosis animal model (ovariotomy rats) in different timing point were measured and analyzed.
目的检测切除卵巢大鼠骨质疏松症模型血清中抗酒石酸酸性磷酸酶5b(tartrate-resistantacidphosphataseform5b,TRACP5b)在术后不同时期的变化,结合药物干预及同期测定的脱氧吡啶啉(Dpd)等骨代谢指标、骨组织形态计量学指标变化,探讨TRACP5b对骨质疏松症诊断和疗效监测的意义。
3) pyridinoline/deoxypyridinoline ratio
吡啶啉/脱氧吡啶啉比值
4) urinary deoxypyridinoline
尿脱氧吡啶啉
1.
Combined determination of urinary deoxypyridinoline and bone alkaline phosphatase and its diagnostic value for osteoporosis;
联合检测尿脱氧吡啶啉与骨源性碱性磷酸酶诊断骨质疏松症
2.
Detection of urinary deoxypyridinoline in patients with spinal tuberculosis and its clinical significance;
脊柱结核病尿脱氧吡啶啉检测及其临床意义
3.
Objective:To study evaluation of detection of urinary deoxypyridinoline for bone obsorption in asthma.
目的探讨尿脱氧吡啶啉(DPD)的检测对应用糖皮质激素治疗的哮喘患者骨吸收的诊断价值。
5) Deoxypyridinoline crosslinks
脱氧吡啶啉交联
6) Urina free deoxypyridinoline
尿游离脱氧吡啶啉
补充资料：脱氧核苷酸钠 ,脱氧核糖核苷酸钠
药物名称：脱氧核糖核苷酸钠
英文名：
别名： DNA单核苷酸钠;脱氧核苷酸钠 ,脱氧核糖核苷酸钠
适应症： 主要用于治疗急性白细胞减少症，对慢性白细胞减少症、再生障碍性贫血等也有一定疗效。
用量用法： 肌注：０．０５ｇ／次，１次／日，疗程不宜超过２～３周。冻干针剂临用前用等渗盐水或注射用水溶解。
规格： 针剂：０．０５ｇ／２ｍｌ；冻干针剂：０．０５ｇ。
类别：促进白细胞增生药
英文名：
别名： DNA单核苷酸钠;脱氧核苷酸钠 ,脱氧核糖核苷酸钠
适应症： 主要用于治疗急性白细胞减少症，对慢性白细胞减少症、再生障碍性贫血等也有一定疗效。
用量用法： 肌注：０．０５ｇ／次，１次／日，疗程不宜超过２～３周。冻干针剂临用前用等渗盐水或注射用水溶解。
规格： 针剂：０．０５ｇ／２ｍｌ；冻干针剂：０．０５ｇ。
类别：促进白细胞增生药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条